CRP and estimating heart disease risk

被引：0
|
作者：
不详
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2003年 / 289卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：974 / 974
页数：1
相关论文
共 50 条
  • [41] Estimating cardiovascular disease risk in diabetes - Reply
    Booth, Gillian L.
    Kapral, Moira K.
    Tu, Jack V.
    LANCET, 2006, 368 (9542): : 1150 - 1150
  • [42] HEART DISEASE RISK REDUCTION
    Betteridge, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [43] Estimating risk of cardiovascular disease in Eastern Europe
    Graham, Ian M.
    EUROPEAN HEART JOURNAL, 2020, 41 (35) : 3334 - 3335
  • [44] Periodontal disease and coronary heart disease risk
    Hujoel, PP
    Drangsholt, M
    Spiekerman, C
    DeRouen, TA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (11): : 1406 - 1410
  • [45] Periodontal disease and risk of coronary heart disease
    Genco, RJ
    Trevisan, M
    Wu, TJ
    Beck, JD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (01): : 40 - 40
  • [46] Gallstone Disease and the Risk of Ischemic Heart Disease
    Lv, Jun
    Qi, Lu
    Yu, Canqing
    Guo, Yu
    Bian, Zheng
    Chen, Yiping
    Yang, Ling
    Shen, Jie
    Wang, Shanqing
    Li, Mingqiang
    Liu, Yongmei
    Zhang, Libo
    Chen, Junshi
    Chen, Zhengming
    Li, Liming
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (10) : 2232 - 2237
  • [47] Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort
    Peikert, Alexander
    Kaier, Klaus
    Merz, Julian
    Manhart, Lucas
    Schaefer, Ibrahim
    Hilgendorf, Ingo
    Hehn, Philipp
    Wolf, Dennis
    Willecke, Florian
    Sheng, Xia
    Clemens, Andreas
    Zehender, Manfred
    von zur Muehlen, Constantin
    Bode, Christoph
    Zirlik, Andreas
    Stachon, Peter
    CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (03) : 315 - 323
  • [48] Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort
    Alexander Peikert
    Klaus Kaier
    Julian Merz
    Lucas Manhart
    Ibrahim Schäfer
    Ingo Hilgendorf
    Philipp Hehn
    Dennis Wolf
    Florian Willecke
    Xia Sheng
    Andreas Clemens
    Manfred Zehender
    Constantin von zur Mühlen
    Christoph Bode
    Andreas Zirlik
    Peter Stachon
    Clinical Research in Cardiology, 2020, 109 : 315 - 323
  • [49] RISK-BENEFIT ASSESSMENT OF DRUG-TREATMENT TO PREVENT CORONARY HEART-DISEASE - ESTIMATING THE BENEFITS OF RISK FACTOR MODIFICATION
    GROVER, SA
    COUPAL, L
    DRUG SAFETY, 1994, 10 (04) : 301 - 309
  • [50] Estimating the causal effect of BMI on mortality risk in people with heart disease, diabetes and cancer using Mendelian randomization
    Jenkins, David A.
    Wade, Kaitlin H.
    Carslake, David
    Bowden, Jack
    Sattar, Naveed
    Loos, Ruth J. F.
    Timpson, Nicholas J.
    Sperrin, Matthew
    Rutter, Martin K.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 : 214 - 220
12345